Literature DB >> 6375900

Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification.

T Olsson, V Kostulas, H Link.   

Abstract

To demonstrate oligoclonal IgG bands (I) in unconcentrated cerebrospinal fluid, we used isoelectric focusing in agarose followed by protein transfer to cellulose nitrate membrane, double-antibody peroxidase labeling, and avidin-biotin amplification. I can be reliably seen after isoelectric focusing of 5-microL specimens containing 125 ng of IgG (25 mg/L). Thus the technique is more sensitive than others (e.g., silver staining) and more reliable than radioimmunofixation. When we used this technique with fluids from 62 patients with multiple sclerosis and infectious disease of the central nervous system, 84% displayed I, a percentage not increased when the same specimens were concentrated to 3.5 g of IgG per liter, examined by agarose isoelectric focusing, and stained with Coomassie Blue. Results for 53 patients with tension headache and psychoneurosis were all negative. By obviating the need to concentrate samples of cerebrospinal fluid the present method is a useful, sensitive alternative for demonstrating I.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375900

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  30 in total

1.  Isolated optic neuritis and its prognosis for multiple sclerosis: a clinical and paraclinical study with evoked potentials. CSF examination and brain MRI.

Authors:  A Ghezzi; V Torri; M Zaffaroni
Journal:  Ital J Neurol Sci       Date:  1996-10

2.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

3.  Cells producing antibody to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls.

Authors:  S Baig; O Olsson; T Olsson; A Löve; S Jeansson; H Link
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

4.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.

Authors:  O Olerup; J Hillert; S Fredrikson; T Olsson; S Kam-Hansen; E Möller; B Carlsson; J Wallin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.

Authors:  A García-Merino; M A Persson; J Ernerudh; J J Díaz-Gil; T Olsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-09       Impact factor: 10.154

6.  Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls.

Authors:  M Cruz; J Ernerudh; T Olsson; B Höjeberg; H Link
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  A case of multiple sclerosis with an onset mimicking the Kleine-Levin syndrome.

Authors:  S Testa; A Opportuno; P Gallo; B Tavolato
Journal:  Ital J Neurol Sci       Date:  1987-04

8.  HLA-DR antigen expression on T cells from cerebrospinal fluid in multiple sclerosis and aseptic meningo-encephalitis.

Authors:  S Fredrikson; A Karlsson-Parra; T Olsson; H Link
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

9.  Elevated cerebrospinal fluid proteins in sciatica caused by disc herniation.

Authors:  J S Skouen; J L Larsen; E Vollset; M Grønning
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

Review 10.  Vaccines for multiple sclerosis: progress to date.

Authors:  Jorge Correale; Mauricio Farez; Wendy Gilmore
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.